Logo image of BXS

Bancorpsouth Inc (BXS) Stock Fundamental Analysis

NYSE:BXS - New York Stock Exchange, Inc. -

28.76  -0.31 (-1.07%)

After market: 29.15 +0.39 (+1.36%)

Fundamental Rating

3

Overall BXS gets a fundamental rating of 3 out of 10. We evaluated BXS against 393 industry peers in the Banks industry. Both the profitability and financial health of BXS have multiple concerns. BXS is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BXS was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 1.09%
ROE 9.76%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin and Gross Margin are not available for BXS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 28.16%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

There is no outstanding debt for BXS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

A Debt/Equity ratio of 0.10 indicates that BXS is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

8

3. Growth

3.1 Past

BXS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.37%, which is quite impressive.
The Earnings Per Share has been growing by 8.60% on average over the past years. This is quite good.
The Revenue has been growing slightly by 7.16% in the past year.
BXS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.67% yearly.
EPS 1Y (TTM)31.37%
EPS 3Y9.17%
EPS 5Y8.6%
EPS Q2Q%-7.02%
Revenue 1Y (TTM)7.16%
Revenue growth 3Y11.46%
Revenue growth 5Y7.67%
Sales Q2Q%7.75%

3.2 Future

Based on estimates for the next years, BXS will show a very strong growth in Earnings Per Share. The EPS will grow by 21.73% on average per year.
The Revenue is expected to grow by 22.94% on average over the next years. This is a very strong growth
EPS Next Y-24.48%
EPS Next 2Y8.72%
EPS Next 3Y12.27%
EPS Next 5Y21.73%
Revenue Next Year16.52%
Revenue Next 2Y31.05%
Revenue Next 3Y21.45%
Revenue Next 5Y22.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BXS Yearly Revenue VS EstimatesBXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
BXS Yearly EPS VS EstimatesBXS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.73, the valuation of BXS can be described as reasonable.
Compared to an average S&P500 Price/Earnings ratio of 26.76, BXS is valued rather cheaply.
BXS is valuated reasonably with a Price/Forward Earnings ratio of 11.26.
BXS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.91.
Industry RankSector Rank
PE 10.73
Fwd PE 11.26
BXS Price Earnings VS Forward Price EarningsBXS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BXS Per share dataBXS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

A more expensive valuation may be justified as BXS's earnings are expected to grow with 12.27% in the coming years.
PEG (NY)N/A
PEG (5Y)1.25
EPS Next 2Y8.72%
EPS Next 3Y12.27%

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.78%, BXS has a reasonable but not impressive dividend return.
BXS's Dividend Yield is comparable with the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

The dividend of BXS is nicely growing with an annual growth rate of 14.77%!
BXS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)14.77%
Div Incr YearsN/A
Div Non Decr YearsN/A
BXS Yearly Dividends per shareBXS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6

5.3 Sustainability

29.41% of the earnings are spent on dividend by BXS. This is a low number and sustainable payout ratio.
The dividend of BXS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP29.41%
EPS Next 2Y8.72%
EPS Next 3Y12.27%
BXS Dividend Payout.BXS Dividend Payout, showing the Payout Ratio.BXS Dividend Payout.PayoutRetained Earnings

More info and screens

Bancorpsouth Inc

NYSE:BXS (10/28/2021, 8:28:46 PM)

After market: 29.15 +0.39 (+1.36%)

28.76

-0.31 (-1.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-25 2021-10-25
Earnings (Next)N/A N/A
Inst Owners0.69%
Inst Owner Change0%
Ins Owners2.3%
Ins Owner Change0%
Market Cap2.95B
Analysts85.8
Price Target34.73 (20.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend0.8
Dividend Growth(5Y)14.77%
DP29.41%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.73
Fwd PE 11.26
P/S 2.77
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB N/A
EV/EBITDA N/A
EPS(TTM)2.68
EY9.32%
EPS(NY)2.55
Fwd EY8.88%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.37
BVpS29.9
TBVpSN/A
PEG (NY)N/A
PEG (5Y)1.25
Profitability
Industry RankSector Rank
ROA 1.09%
ROE 9.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 28.16%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.37%
EPS 3Y9.17%
EPS 5Y8.6%
EPS Q2Q%-7.02%
EPS Next Y-24.48%
EPS Next 2Y8.72%
EPS Next 3Y12.27%
EPS Next 5Y21.73%
Revenue 1Y (TTM)7.16%
Revenue growth 3Y11.46%
Revenue growth 5Y7.67%
Sales Q2Q%7.75%
Revenue Next Year16.52%
Revenue Next 2Y31.05%
Revenue Next 3Y21.45%
Revenue Next 5Y22.94%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A